TITLE

Esomeprazole maintains control of upper GI symptoms in patients on NSAID therapy

AUTHOR(S)
Scheiman, J M; Yeomans, N; Hawkey, C J; Talley, N J; Sung, J; Jones, R
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS3
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Esomeprazole Maintains Control of Upper GI Symptoms in Patients on NSAID Therapy," by J. M. Scheiman, N. Yeomans, C. J. Hawkey, N. J. Talley, and J. Sung R. Jones is presented.
ACCESSION #
66954564

 

Related Articles

  • News in brief . . .  // Reactions Weekly;6/4/2005, Issue 1054, p4 

    Presents three medical research. Results of a study on the comparison of esomeprazole, lansoprazole and pantoprazole; Information on a study on nonsteroidal anti-inflammatory drug; Facts about a study on the cardiovascular risk factors after antenatal exposure to betamethasone.

  • Aspirin plus esomeprazole reduced recurrent ulcer bleeding more than clopidogrel in high-risk patients. Peterson, Walter L. // ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p24 

    This article presents information on a study related to clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. In patients with previous aspirin-induced ulcer bleeding, the addition of esomeprazole to aspirin was better than changing to clopidogrel for decreasing...

  • Risk-Management for Persons at High Risk of GI Bleeding.  // Travel Medicine Advisor;Aug2007, Vol. 17 Issue 8, p16 

    The article discusses a study on the appropriate steps for risk reduction in patients taking NSAIDs. There is a risk of rebleeding in persons with a history of ulcer bleeding if traditional NSAID only is administered. The study revealed that COX-2 inhibitors should always be taken together with...

  • Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin. Yeomans, Neville; Lanas, Angel; Labenz, Joachim; van Zanten, Sander Veldhuyzen; van Rensburg, Christoffel; Rácz, Istvan; Tchernev, Konstantin; Karamanolis, Dimitrios; Roda, Enrico; Hawkey, Chris; Nauclér, Emma; Svedberg, Lars-Erik // American Journal of Gastroenterology;Oct2008, Vol. 103 Issue 10, p2465 

    OBJECTIVES: Low-dose aspirin is standard treatment for prevention of cardiovascular events in at-risk patients. However, long-term administration of low-dose aspirin is associated with a greater risk of adverse events, including gastroduodenal ulcers. This study determined the efficacy of...

  • Esomeprazole/nonsteroidal anti-inflammatories.  // Reactions Weekly;5/4/2013, Issue 1451, p20 

    The article describes the case of an elderly woman with oesophageal reflux who developed collagenous colitis while receiving esomeprazole and nonsteroidal anti-inflammatories (NSAID).

  • Celecoxib combined with esomeprazole prevented recurrent ulcer bleeding in patients with previous NSAID- induced ulcer bleeding: COMMENTARY. Katz, Philip O. // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p38 

    The article reports on prevention of recurrent ulcer bleeding in patients with previous NonSteroidal AntiInflammatory Drug (NSAID)- induced ulcer bleeding through treatment with combination of celecoxib and esomeprazole. It reports on higher occurrence of GastroIntestinal (GI) complications in...

  • Esomeprazole may reduce NSAID-induced upper GI disorders.  // Reactions Weekly;5/28/2005, Issue 1053, p4 

    Discusses research being done on the efficacy, tolerability and safety of esomeprazole therapy for upper gastrointestinal symptoms related to the use of nonsteroidal anti-inflammatory drugs. Reference to a study by C. Hawkey and colleagues, published in the May 2005 issue of the "American...

  • Celecoxib + esomeprazole effective in haemorrhage prevention.  // Reactions Weekly;5/19/2007, Issue 1152, p1 

    The article describes a study of the effectiveness of the combination of the COX 2 inhibitor celecoxib and the proton pump inhibitor (PPI) esomeprazole in preventing recurrent ulcer haemorrhage in high-risk patients. The cumulative incidence of the primary endpoint was 0% in the combined...

  • Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors. Scheiman, James M.; Yeomans, Neville D.; Talley, Nicholas J.; Vakil, Nimish; Chan, Francis K. L.; Tulassay, Zsolt; Rainoldi, Jorge L.; Szczepanski, Leszek; Ung, Kjell-Arne; Kleczkowski, Dariusz; Ahlbom, Henrik; Næsdal, Jørgen; Hawkey, Christopher // American Journal of Gastroenterology;Apr2006, Vol. 101 Issue 4, p701 

    OBJECTIVES: Proton pump inhibitors reduce ulcer recurrence in non-steroidal anti-inflammatory drug (NSAID) users, but their impact in at-risk ulcer-free patients using the current spectrum of prescribed agents has not been clearly defined. We assessed esomeprazole for ulcer prevention in at-risk...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics